semaglutide and ketamine PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic in Canada, Building on FDA-Approved Success Discovering Hope: Ketamine Treatments |

Our proprietary, science-backed ingredient in Evolv GLP-1 helps to: Support weight loss and metabolism* Curb cravings and regulate appetite* Support healthy blood glucose levels* Improve digestion and gut health*

It includes a C-18 fatty acid chain attached to the peptide backbone that enables it to bind to albumin in the blood, extending its half-life to approximately one week

LOMAIRA is FDA-approved to be used up to three times a day, as prescribed by a healthcare professional

What to Expect: Timeline Weeks 1-2 (Tesamorelin only) Improved sleep quality (deeper, more restorative) Possible mild water retention or joint stiffness Subtle recovery improvement between workouts Weeks 3-4 Sleep benefits continue Beginning to see body composition shifts (less bloated, more definition) Appetite stable (Reta handles this) Weeks 5-6 (add MOTS-C) Energy levels stabilize or improve Training endurance increases (especially cardio) Fat loss may accelerate Weeks 8-12 Visible visceral fat reduction Improved muscle definition and separation Better workout performance and recovery Body recomposition effects compound Side Effects and Management Tesamorelin Joint stiffness: Temporary, usually subsides by week 3

Semaglutide 1 mg injection (Ozempic) was first approved as a treatment for type 2 diabetes in 2017

Conducted on 2,339 participants, the study revealed that those on a 12 mg dose lost an average of 70.3 lbs (28.3%) over 80 weeks